Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IDYA
IDYA logo

IDYA News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IDYA News

IDEAYA Biosciences Appoints New Chairman

Jun 17 2026NASDAQ.COM

IDEAYA Biosciences Elects New Chairman of the Board

Jun 17 2026PRnewswire

IDEAYA Biosciences Appoints New Chairman

Jun 17 2026Newsfilter

IDEAYA Launches Phase 1 Trial for IDE892 in Cancer Treatment

Jun 15 2026PRnewswire

IDEAYA Biosciences Launches IDE892 Clinical Trial for MTAP-Deleted Cancers

Jun 15 2026Newsfilter

IDEAYA Biosciences Completes Public Offering Raising $345 Million

Jun 10 2026PRnewswire

IDEAYA Biosciences Prices Public Offering at $27 per Share

Jun 09 2026NASDAQ.COM

IDEAYA Biosciences Raises $300M in Public Offering

Jun 09 2026seekingalpha

IDYA Events

06/17 07:00
Ideaya Biosciences Appoints Yujiro Hata as Chairman of the Board
Ideaya Biosciences announced that its board of directors has elected Yujiro Hata, chairman of the board. Hata is currently president and CEO, and a member of Ideaya's board. Terry Rosen will serve as lead independent director of Ideaya's board.
06/15 06:30
Ideaya Biosciences Begins Phase 1 Trial for IDE892
Ideaya Biosciences announced that the first patient has been enrolled in its Phase 1 clinical trial evaluating IDE892, a methylthioadenosine-cooperative inhibitor of PRMT5, in combination with IDE397, an inhibitor of MAT2A, in MTAP-deleted solid tumors, with a focus on NSCLC and pancreatic cancer. In preclinical studies, dual inhibition of PRMT5 and MAT2A with the combination of IDE892 and IDE397 resulted in potent anti-tumor activity in MTAP-deleted tumor models, including complete and durable responses at well-tolerated doses below those required for monotherapy activity.
06/08 19:20
Energy and Tech Sectors Perform Strong Amid Middle East Tensions
Tech and Energy sectors in the S&P 500 have rarely tracked together over the past few months, with headlines related to Middle East tensions driving up inflation fears, which were then felt through upward pressure in Treasury yields while discouraging inflows into higher-beta areas of the market.  On Monday, however, Energy and Tech were the best two sectors in the S&P 500 amid sustained escalation between US and Iran as well as a bounce-back in Semiconductors and Computer Hardware names following Friday's rout.   In turn, the less-cyclical Utilities was the worst performing sector today and also bears the distinction of the biggest loser since the U.S.-Iran war began in early March, as yield-seeking funds opted for higher fixed income allocations.In the opening hour of the evening session, NASDAQ 100 contract and S&P E-minis are both down by a decimal.  In commodities, WTI crude oil remains above $91 per barrel despite comments from President Trump in a press interview promising the end of Iran war in two weeks.  Metals have also remained under pressure following Friday's sell-off - gold trades at $4,350 and silver is staying well below $70 per ounce.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Gloo Holdingsup 5.1%ALSO HIGHER -Applied Digitalup 8.4% after announcing new long-term lease agreement at Delta Forge 2DOWN AFTER EARNINGS -Mission Producedown 5.0%Vail Resortsdown 4.2%ALSO LOWER -IDEAYA Biosciencesdown 7.8% after equity offering

IDYA Monitor News

IDEAYA Biosciences Prices $300 Million Public Offering

Jun 09 2026

IDEAYA to Announce Phase 2/3 Trial Results for Darovasertib

Apr 13 2026

IDYA Earnings Analysis

No Data

No Data

People Also Watch